By: IPP Bureau
Last updated : June 23, 2026 8:50 am
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
Shilpa Biologicals Private Limited (SBPL) has announced the launch of PartnerPower, a purpose-built digital transparency platform designed to provide global biopharmaceutical sponsors with uninterrupted, real-time visibility into every stage of their biologics development and manufacturing programs.
Developed as a unified digital data fabric, PartnerPower moves beyond traditional periodic reporting models by creating a continuously connected and collaborative environment.
The platform enables sponsors to monitor the real-time status of their projects from anywhere in the world, offering direct access to operational data generated across process development laboratories and GMP manufacturing facilities.
By integrating information across research and development, analytical development and manufacturing operations, the platform is designed to support seamless collaboration, accelerate decision-making and facilitate more efficient technology transfer between Shilpa Biologicals and its partners.
The launch forms part of Shilpa Biologicals’ broader strategy to redefine the Contract Development and Manufacturing Organization (CDMO) experience by transitioning from a conventional outsourcing model to a more integrated, partnership-driven approach focused on transparency, trust and operational excellence.
A key feature of PartnerPower is its emphasis on data integrity, sponsor confidentiality and regulatory compliance. The platform has been developed in alignment with the expectations of major global regulatory authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). It is designed to support continuous audit readiness while ensuring secure access to critical project information.
Madhav Bhutada, Director, Shilpa Biologicals, said, “With PartnerPower, we are setting a new global benchmark for what transparency in a CDMO partnership should look like. It allows our sponsors to innovate with complete confidence, knowing that every data point, every decision, and milestone is visible to them in real time.”
The company will showcase its capabilities and the PartnerPower platform at BIO International Convention 2026 in San Diego, where visitors can meet the team at Booth No. 3351.